{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:11:23Z","timestamp":1770819083486,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS077022"],"award-info":[{"award-number":["NS077022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bbr.2018.01.029","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T07:34:41Z","timestamp":1517643281000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein"],"prefix":"10.1016","volume":"343","author":[{"given":"Emily R.","family":"Dirr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osunde R.","family":"Ekhator","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Blackwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Schultheis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2018.01.029_bib0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbrc.2004.08.156","article-title":"Characterization of the P5 subfamily of P-type transport ATPases in mice","volume":"323","author":"Schultheis","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2018.01.029_bib0010","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/ddr606","article-title":"PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity","volume":"21","author":"Ramonet","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0015","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type 13A2ase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0025","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2018.01.029_bib0030","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, \u03b1-synuclein accumulation, and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.01.029_bib0035","doi-asserted-by":"crossref","first-page":"9040","DOI":"10.1073\/pnas.1508220112","article-title":"A lipid switch unlocks Parkinson\u2019s disease-associated ATP13A2","volume":"112","author":"Holemans","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2018.01.029_bib0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2011.12.035","article-title":"ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome","volume":"33","author":"Gr\u00fcnewald","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2018.01.029_bib0045","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.nbd.2011.12.015","article-title":"ATP13A2 regulates mitochondrial bioenergetics through macroautophagy","volume":"45","author":"Gusdon","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2018.01.029_bib0050","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/hmg\/ddt623","article-title":"Parkinson\u2019s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction","volume":"23","author":"Park","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.bbr.2018.01.029_bib0055","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","article-title":"Parkinson\u2019s disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes \u03b1-synuclein externalization via exosomes","volume":"23","author":"Kong","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0060","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddt572","article-title":"Zn2+ dyshomeostasis caused by loss of ATP13A2\/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation","volume":"23","author":"Tsunemi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0065","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the Parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2018.01.029_bib0075","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1093\/hmg\/dds206","article-title":"Identification of novel ATP13A2 interactors and their role in \u03b1-synuclein misfolding and toxicity","volume":"21","author":"Usenovic","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4161\/auto.20256","article-title":"Lysosomal dysfunction in neurodegeneration: the role of ATP13A2\/PARK9","volume":"8","author":"Usenovic","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.bbr.2018.01.029_bib0085","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/brain\/aww111","article-title":"Genetic and phenotypic characterization of complex hereditary spastic paraplegia","volume":"139","author":"Kara","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2018.01.029_bib0090","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile Parkinsonism and young onset Parkinson disease","volume":"68","author":"Fonzo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2018.01.029_bib0095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000335167.72412.68","article-title":"Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore","volume":"71","author":"Lin","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2018.01.029_bib0100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.26243","article-title":"The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms","volume":"30","author":"Park","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2018.01.029_bib0105","first-page":"5483","article-title":"Additional rare variant analysis in Parkinson\u2019s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s40572-017-0143-2","article-title":"Mechanisms of gene-environment interactions in Parkinson\u2019s disease","volume":"4","author":"Fleming","year":"2017","journal-title":"Curr. Environ. Health Rep."},{"key":"10.1016\/j.bbr.2018.01.029_bib0115","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with Parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.01.029_bib0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in drosophila PINK1 mutants is complemented by Parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.01.029_bib0125","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase 2 (LRRK2) interacts with Parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2018.01.029_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2018.01.029_bib0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2014.11.027","article-title":"Parkinson\u2019s disease genes VPS35 and EIF4G1 interact genetically and converge on \u03b1-synuclein","volume":"85","author":"Dhungel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2018.01.029_bib0140","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2014.10.007","article-title":"\u03b1-synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson\u2019s disease occurs independent of ATP13A2 (PARK9)","volume":"73C","author":"Daniel","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2018.01.029_bib0150","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","article-title":"\u03b1-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2","volume":"5","author":"Kett","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.01.029_bib0155","first-page":"30101","article-title":"The effect of manganese exposure on sensorimotor function and alpha-synuclein accumulation in Atp13a2-deficient mice","volume":"17","author":"Fleming","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2018.01.029_bib0160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1602\/neurorx.2.3.495","article-title":"Genetic mouse models of Parkinsonism: strengths and limitations","volume":"2","author":"Fleming","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbr.2018.01.029_bib0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0170","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive motor abnormalities in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.01.029_bib0175","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.neuroscience.2006.07.005","article-title":"Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype \u03b1-synuclein","volume":"142","author":"Fleming","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2018.01.029_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","article-title":"Olfactory dysfunction in mice overexpressing human wildtype alpha-synuclein","volume":"28","author":"Fleming","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"2011","key":"10.1016\/j.bbr.2018.01.029_bib0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mcn.2010.12.011","article-title":"The microtubule assembly promoting protein (NAP) improves motor function and reduces alpha synuclein inclusions in mice overexpressing alpha synuclein","volume":"46","author":"Fleming","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2018.01.029_bib0190","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.202.4373.1216","article-title":"6-Hydroxydopamine and anticholinergic drugs","volume":"202","author":"Schallert","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.bbr.2018.01.029_bib0195","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0200","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.1002\/prp2.65","article-title":"Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing \u03b1-synuclein","volume":"2","author":"Magen","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2018.01.029_bib0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","article-title":"Abnormal colonic motility in mice overexpressing human wildtype alpha-synuclein","volume":"19","author":"Wang","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2018.01.029_bib0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2018.01.029_bib0215","first-page":"2959","article-title":"A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death","volume":"25","author":"Lopes da Fonseca","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2018.01.029_bib0220","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/jnr.22327","article-title":"Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway","volume":"88","author":"Wu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbr.2016.02.017","article-title":"The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson\u2019s disease","volume":"304","author":"Gerstenberger","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson\u2019s disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2018.01.029_bib0235","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbr.2018.01.029_bib0240","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbr.2018.01.029_bib0245","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pbb.2010.03.009","article-title":"Sex differences in motor behavior in the MPTP mouse model of Parkinson\u2019s disease","volume":"95","author":"Antzoulatos","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2018.01.029_bib0250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2009.07.011","article-title":"Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL\/6 mice","volume":"311","author":"Ookubo","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbr.2018.01.029_bib0255","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neuro.2008.02.014","article-title":"Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits","volume":"29","author":"Liu","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2018.01.029_bib0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2006.07.004","article-title":"Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson\u2019s disease","volume":"174","author":"Field","year":"2006","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2008.12.081","article-title":"Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"1261","author":"Joniec","year":"2009","journal-title":"Brain. Res."},{"key":"10.1016\/j.bbr.2018.01.029_bib0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1385\/ENDO:29:2:275","article-title":"Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson\u2019s disease","volume":"29","author":"Tam\u00e1s","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.bbr.2018.01.029_bib0275","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2009.06350.x","article-title":"Absence of nigral degeneration in aged Parkin\/DJ-1\/PINK1 triple knockout mice","volume":"111","author":"Kitada","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2018.01.029_bib0280","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2018.01.029_bib0285","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1523\/JNEUROSCI.0414-06.2006","article-title":"Inclusion body formation and neurodegeneration are Parkin independent in a mouse model of alpha-synucleinopathy","volume":"26","author":"von Coelln","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2018.01.029_bib0290","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1080\/15384101.2015.1093420","article-title":"Unlocking ATP13A2\/PARK9 activity","volume":"14","author":"Martin","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbr.2018.01.029_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0854.2011.01246.x","article-title":"Phosphatidylinositol-3,5-bisphosphate: no longer the poor PIP2","volume":"13","author":"Ho","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.bbr.2018.01.029_bib0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncomms1037","article-title":"PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome","volume":"1","author":"Dong","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2018.01.029_bib0305","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/46587","article-title":"CtBP\/BARS induces fission of golgi membranes by acylating lysophosphatidic acid","volume":"402","author":"Weigert","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2018.01.029_bib0310","doi-asserted-by":"crossref","first-page":"C1279","DOI":"10.1152\/ajpcell.1997.272.4.C1279","article-title":"Phospholipase D activity facilitates Ca2+-induced aggregation and fusion of complex liposomes","volume":"272","author":"Blackwood","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbr.2018.01.029_bib0315","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.1066015","article-title":"Phosphatidic acid-mediated mitogenic activation of mTOR signaling","volume":"294","author":"Fang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbr.2018.01.029_bib0320","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2014.06.017","article-title":"Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein","volume":"70","author":"Subramaniam","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2018.01.029_bib0325","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"Mak","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281731001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643281731001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:06:30Z","timestamp":1759064790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643281731001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":65,"alternative-id":["S016643281731001X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2018.01.029","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2018.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}